112 related articles for article (PubMed ID: 2340605)
1. Syntheses of polymeric vesicles containing partial structures of N-acetyl-muramyl-dipeptide (MDP).
Hönig H; Zenk R
Chem Phys Lipids; 1990 Mar; 53(4):347-56. PubMed ID: 2340605
[TBL] [Abstract][Full Text] [Related]
2. Immunoadjuvant effects of the synthetic muramyl-dipeptide (MDP) N-acetylmuramyl-L-alanyl-D-isoglutamine.
Heymer B; Finger H; Wirsing CH
Z Immunitatsforsch Immunobiol; 1978 Oct; 155(1):87-92. PubMed ID: 706536
[TBL] [Abstract][Full Text] [Related]
3. Activation of murine Kupffer cell tumoricidal activity by liposomes containing lipophilic muramyl dipeptide.
Phillips NC; Rioux J; Tsao MS
Hepatology; 1988; 8(5):1046-50. PubMed ID: 2971013
[TBL] [Abstract][Full Text] [Related]
4. The immunopotentiating property of lipophilic muramyl dipeptide and its molecular state in liposomal membranes: plaque-forming cell responses and ESR studies.
Manabe H; Utsumi H; Kusama T; Hamada A
J Biochem; 1989 Jun; 105(6):861-3. PubMed ID: 2549019
[TBL] [Abstract][Full Text] [Related]
5. N-acetyl muramyl dipeptide stimulation of bone resorption in tissue culture.
Dewhirst FE
Infect Immun; 1982 Jan; 35(1):133-7. PubMed ID: 7054120
[TBL] [Abstract][Full Text] [Related]
6. Degradation of muramyl dipeptide by mammalian serum.
Harrison J; Fox A
Infect Immun; 1985 Oct; 50(1):320-1. PubMed ID: 3876287
[TBL] [Abstract][Full Text] [Related]
7. Stereo-isomer specific induction of renal cell apoptosis by synthetic muramyl dipeptide (N-acetylmuramyl-L-alanyl-D-isoglutamine).
Langford MP; Chen D; Welbourne TC; Redens TB; Ganley JP
Mol Cell Biochem; 2002 Jul; 236(1-2):63-73. PubMed ID: 12190122
[TBL] [Abstract][Full Text] [Related]
8. Chemical modification of the C-6 substituent in the carbohydrate moiety of N-acetylmuramoyl-L-alanyl-D-isoglutamine (MDP), and the immunoadjuvant activity.
Okumura H; Tokushima Y; Saiki I; Azuma I; Kiso M; Hasegawa A
Carbohydr Res; 1983 Oct; 122(1):87-98. PubMed ID: 6652634
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and immunoadjuvant activities of 2-acetamido-5-O-acetyl-6-O-acyl-2-deoxy-3-O-[(R)-2-propionyl-L-alanyl-D- isoglutamine]-D-glucofuranoses as potential prodrug forms of 6-O-Acyl Derivatives of N-acetylmuramyl dipeptide.
Durette PL; Dorn CP; Friedman A; Schlabach A
J Med Chem; 1982 Sep; 25(9):1028-33. PubMed ID: 7131480
[TBL] [Abstract][Full Text] [Related]
10. Calreticulin is a binding protein for muramyl dipeptide and peptidoglycan in RK13 cells.
Chen D; Duggan C; Reden TB; Kooragayala LM; Texada DE; Langford MP
Biochemistry; 2004 Sep; 43(37):11796-801. PubMed ID: 15362864
[TBL] [Abstract][Full Text] [Related]
11. Synthesis of N-acetyl-muramyl-L-alanyl-D-glutamic-alpha-amide(MDP) or -alpha-methyl ester derivatives, bearing a lipophilic group at the C-terminal peptide end.
Lefrancier P; Petitou M; Level M; Derrien M; Choay J; Lederer E
Int J Pept Protein Res; 1979; 14(5):437-44. PubMed ID: 536111
[TBL] [Abstract][Full Text] [Related]
12. Fate of the synthetic immunoadjuvant, muramyl dipeptide (14C-labelled) in the mouse.
Parant M; Parant F; Chedid L; Yapo A; Petit JF; Lederer E
Int J Immunopharmacol; 1979; 1(1):35-41. PubMed ID: 551094
[TBL] [Abstract][Full Text] [Related]
13. Opposite effects of the synthetic adjuvant N-acetyl-muramyl-L-alanyl-D-isoglutamine on the immune response in mice depending on experimental conditions.
Souvannavong V; Adam A
Eur J Immunol; 1980 Aug; 10(8):654-6. PubMed ID: 6995138
[TBL] [Abstract][Full Text] [Related]
14. In vivo regulation of humoral and cellular immune responses of mice by a synthetic adjuvant, N-acetyl-muramyl-L-alanyl-D-isoglutamine, muramyl dipeptide for MDP.
Leclerc C; Juy D; Bourgeois E; Chedid L
Cell Immunol; 1979 Jun; 45(1):199-206. PubMed ID: 313275
[No Abstract] [Full Text] [Related]
15. Lack of immunostimulatory effect of N-acetyl muramyl-L-alanyl-D-isoglutamine on selected chicken immune functions.
Neumann U; Wischner H; Siegmann O
Comp Immunol Microbiol Infect Dis; 1982; 5(4):413-21. PubMed ID: 7172620
[TBL] [Abstract][Full Text] [Related]
16. Analysis of the antigenic relationship of various derivatives of n-acetyl-muramyl-l-ala-d-isoglutamine (MDP), using anti-MDP antibodies.
Bahr GM; Carelli C; Audibert F; Modabber F; Chedid L
Mol Immunol; 1982 May; 19(5):737-45. PubMed ID: 7110143
[TBL] [Abstract][Full Text] [Related]
17. Protective effect of muramyl dipeptide analogs against infections of Pseudomonas aeruginosa or Candida albicans in mice.
Fraser-Smith EB; Matthews TR
Infect Immun; 1981 Dec; 34(3):676-83. PubMed ID: 7333666
[TBL] [Abstract][Full Text] [Related]
18. [Partial characterization of thymocyte activating factor derived from guinea pig fibroblast stimulated with muramyl dipeptide (MDP)].
Kabashima H; Iribe H; Koga T
Fukuoka Igaku Zasshi; 1988 May; 79(5):362-74. PubMed ID: 3262078
[No Abstract] [Full Text] [Related]
19. Muramyl dipeptide analogues as potentiators of the antitumor action of endotoxin.
Bloksma N; Hofhuis FM; Willers JM
Cancer Immunol Immunother; 1985; 19(3):205-10. PubMed ID: 3847290
[TBL] [Abstract][Full Text] [Related]
20. Induction of murine macrophage tumoricidal activity and treatment of experimental pulmonary metastases by liposomes containing lipophilic muramyl dipeptide analogs.
Phillips NC; Chedid L; Bernard JM; Level M; Lefrancier P
J Biol Response Mod; 1987 Dec; 6(6):678-91. PubMed ID: 3450784
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
